July 19, 2025
Sialylated Glycoproteins-Siglec Pathway: A New Target for Prostate Cancer Immunotherapy
Introduction On October 22, 2024, the team of James D. Brooks from Stanford University published an article entitled "Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer" in The Journal of Clinical Investigation. This article focuses on the key role of glycosylation in the immune escape of Prostate Cancer […]
Read More >
